Restrictive transfusion method safe in cardiac surgery patients

Print Friendly, PDF & Email


Blood for transfusion
Photo by Elise Amendola
Results of a large study suggest a restrictive transfusion strategy is safe for moderate- to high-risk patients undergoing cardiac surgery. Researchers found that patients had similar rates of various outcomes—death from any cause, myocardial infarction, stroke, or new-onset renal failure with dialysis—whether they received red blood... [Read Article]
Print Friendly, PDF & Email

Automated blood analyzers approved in China

Print Friendly, PDF & Email


Technician using
ORTHO VISION Max
Photo from PR Newswire/
Ortho Clinical Diagnostics
The China Food and Drug Administration has approved Ortho Clinical Diagnostics’ ORTHO VISION® Platform of fully automated blood analyzers for transfusion medicine laboratories. The platform consists of ORTHO VISION and ORTHO VISION Max. ORTHO VISION is a blood analyzer designed for small-... [Read Article]
Print Friendly, PDF & Email

Results support early blood transfusion

Print Friendly, PDF & Email


Blood for transfusion
Photo from UAB Hospital
Early blood transfusion is associated with improved survival among people with severe trauma sustained during combat, according to research published in JAMA. Researchers studied medically evacuated US military personnel fighting in Afghanistan and found that patients who received blood products prior to hospitalization or within 15... [Read Article]
Print Friendly, PDF & Email

FDA issues EUA for Zika virus test

Print Friendly, PDF & Email


Blood samples
Photo by Graham Colm
The US Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for Thermo Fisher Scientific’s TaqPath Zika Virus Kit. This means the TaqPath Zika Virus Kit is authorized for the qualitative detection of RNA from Zika virus and diagnosis of Zika virus infection in... [Read Article]
Print Friendly, PDF & Email

FDA clears new plasmapheresis system

Print Friendly, PDF & Email


NexSys PCS
plasmapheresis system
PRNewsfoto/
Haemonetics Corporation
The US Food and Drug Administration (FDA) has granted 510(k) clearance for Haemonetics Corporation’s NexSys PCS™ plasmapheresis system. The open architecture of NexSys PCS facilitates bi-directional connectivity to donor management systems, enabling automated collection procedure programming and automated end-of-procedure documentation. The guided operation, large touch screen,... [Read Article]
Print Friendly, PDF & Email